{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:42:50Z","timestamp":1780940570521,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"VA HSR&D Research Career Scientist award","award":["RCS 14-132"],"award-info":[{"award-number":["RCS 14-132"]}]},{"name":"VA HSR&D Career Development award","award":["CDA12-276"],"award-info":[{"award-number":["CDA12-276"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13722-019-0134-8","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:03:57Z","timestamp":1549929837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions"],"prefix":"10.1186","volume":"14","author":[{"given":"Emily C.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa E.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H. S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"issue":"4","key":"134_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1176\/ps.2010.61.4.392","volume":"61","author":"AH Harris","year":"2010","unstructured":"Harris AH, Kivlahan DR, Bowe T, Humphreys KN. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv. 2010;61(4):392\u20138.","journal-title":"Psychiatr Serv"},{"issue":"9458","key":"134_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0140-6736(05)70276-2","volume":"365","author":"R Room","year":"2005","unstructured":"Room R, Babor T, Rehm J. Alcohol and public health. Lancet. 2005;365(9458):519\u201330.","journal-title":"Lancet"},{"issue":"10","key":"134_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","volume":"291","author":"AH Mokdad","year":"2004","unstructured":"Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238\u201345.","journal-title":"JAMA"},{"issue":"2\u20133","key":"134_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.06.008","volume":"86","author":"E Cohen","year":"2007","unstructured":"Cohen E, Feinn R, Arias A, Kranzler HR. Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007;86(2\u20133):214\u201321.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"134_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1037\/a0030949","volume":"10","author":"AH Harris","year":"2013","unstructured":"Harris AH, Ellerbe L, Reeder RN, et al. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychol Serv. 2013;10(4):410\u20139.","journal-title":"Psychol Serv"},{"issue":"1\u20133","key":"134_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.drugalcdep.2008.07.018","volume":"99","author":"TL Mark","year":"2009","unstructured":"Mark TL, Kassed CA, Vandivort-Warren R, Levit KR, Kranzler HR. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009;99(1\u20133):345\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"18","key":"134_CR7","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2014.3628","volume":"311","author":"DE Jonas","year":"2014","unstructured":"Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311(18):1889\u2013900.","journal-title":"JAMA"},{"issue":"1","key":"134_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jsat.2006.12.004","volume":"33","author":"AT McLellan","year":"2007","unstructured":"McLellan AT. Reducing heavy drinking: a public health strategy and a treatment goal? J Subst Abuse Treat. 2007;33(1):81\u20133.","journal-title":"J Subst Abuse Treat"},{"issue":"17","key":"134_CR9","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","volume":"295","author":"RF Anton","year":"2006","unstructured":"Anton RF, O\u2019Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003\u201317.","journal-title":"JAMA"},{"issue":"1","key":"134_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsat.2006.09.008","volume":"33","author":"DR Gastfriend","year":"2007","unstructured":"Gastfriend DR, Garbutt JC, Pettinati HM, Forman RF. Reduction in heavy drinking as a treatment outcome in alcohol dependence. J Subst Abuse Treat. 2007;33(1):71\u201380.","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"134_CR11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1037\/a0030563","volume":"27","author":"AK Davis","year":"2013","unstructured":"Davis AK, Rosenberg H. Acceptance of non-abstinence goals by addiction professionals in the United States. Psychol Addict Behav. 2013;27(4):1102\u20139.","journal-title":"Psychol Addict Behav"},{"issue":"4","key":"134_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/1556035X.2017.1348280","volume":"12","author":"DC Wendt","year":"2017","unstructured":"Wendt DC, Gone JP. Group therapy for substance use disorders: a survey of clinician practices. J Groups Addict Recovery. 2017;12(4):243\u201359.","journal-title":"J Groups Addict Recovery"},{"issue":"14","key":"134_CR13","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1001\/jama.298.14.1691","volume":"298","author":"ML Willenbring","year":"2007","unstructured":"Willenbring ML. Medications to treat alcohol dependence: adding to the continuum of care. JAMA. 2007;298(14):1691\u20132.","journal-title":"JAMA"},{"issue":"18","key":"134_CR14","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1001\/jama.2014.3629","volume":"311","author":"KA Bradley","year":"2014","unstructured":"Bradley KA, Kivlahan DR. Bringing patient-centered care to patients with alcohol use disorders. JAMA. 2014;311(18):1861\u20132.","journal-title":"JAMA"},{"key":"134_CR15","unstructured":"Department of Veterans Affairs. VA\/DoD clinical practice guideline for the management of substance use disorders. 2015. \n                    http:\/\/www.healthquality.va.gov\/guidelines\/MH\/sud\/VADoDSUDCPGRevised22216.pdf\n                    \n                  . Accessed 11 July 2018."},{"key":"134_CR16","volume-title":"National voluntary consensus standards for the treatment of substance use conditions: evidence-based treatment practices","author":"National Quality Forum","year":"2007","unstructured":"National Quality Forum. National voluntary consensus standards for the treatment of substance use conditions: evidence-based treatment practices. Washington: National Quality Forum; 2007."},{"issue":"7","key":"134_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1176\/appi.ps.201000553","volume":"63","author":"AH Harris","year":"2012","unstructured":"Harris AH, Oliva E, Bowe T, Humphreys KN, Kivlahan DR, Trafton JA. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatr Serv. 2012;63(7):679\u201385.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"134_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1377\/hlthaff.2011.1319","volume":"31","author":"AH Harris","year":"2012","unstructured":"Harris AH. Too few patients medicated for alcohol dependence. Health Aff (Millwood). 2012;31(1):249 (author reply 250).","journal-title":"Health Aff (Millwood)"},{"key":"134_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jpsychires.2015.07.016","volume":"69","author":"AD Rubinsky","year":"2015","unstructured":"Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. J Psychiatr Res. 2015;69:150\u20137.","journal-title":"J Psychiatr Res"},{"key":"134_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.drugalcdep.2017.06.011","volume":"178","author":"EC Williams","year":"2017","unstructured":"Williams EC, Gupta S, Rubinsky AD, et al. Variation in receipt of pharmacotherapy for alcohol use disorders across racial\/ethnic groups: a national study in the U.S. Veterans Health Administration. Drug Alcohol Depend. 2017;178:527\u201333.","journal-title":"Drug Alcohol Depend"},{"key":"134_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.drugalcdep.2017.01.018","volume":"174","author":"EC Williams","year":"2017","unstructured":"Williams EC, Lapham GT, Shortreed SM, et al. Among patients with unhealthy alcohol use, those with HIV are less likely than those without to receive evidence-based alcohol-related care: a national VA study. Drug Alcohol Depend. 2017;174:113\u201320.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"134_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s11606-017-4202-z","volume":"33","author":"EC Williams","year":"2017","unstructured":"Williams EC, Achtmeyer CE, Young JP, et al. Barriers to and facilitators of Alcohol Use Disorder Pharmacotherapy in Primary Care: a qualitative study in five VA clinics. J Gen Intern Med. 2017;33(3):258\u201367.","journal-title":"J Gen Intern Med"},{"key":"134_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2017.03.005","volume":"77","author":"AK Finlay","year":"2017","unstructured":"Finlay AK, Ellerbe LS, Wong JJ, et al. Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs. J Subst Abuse Treat. 2017;77:38\u201343.","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"134_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s11920-011-0222-2","volume":"13","author":"EM Oliva","year":"2011","unstructured":"Oliva EM, Maisel NC, Gordon AJ, Harris AH. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011;13(5):374\u201381.","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"134_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1521-0391.2003.tb00543.x","volume":"12","author":"TL Mark","year":"2003","unstructured":"Mark TL, Kranzler HR, Poole VH, Hagen CA, McLeod C, Crosse S. Barriers to the use of medications to treat alcoholism. Am J Addict. 2003;12(4):281\u201394.","journal-title":"Am J Addict"},{"issue":"3","key":"134_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0376-8716(03)00134-0","volume":"71","author":"TL Mark","year":"2003","unstructured":"Mark TL, Kranzler HR, Song X. Understanding US addiction physicians\u2019 low rate of naltrexone prescription. Drug Alcohol Depend. 2003;71(3):219\u201328.","journal-title":"Drug Alcohol Depend"},{"key":"134_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1046\/j.1360-0443.2003.00377.x","volume":"98","author":"TL Mark","year":"2003","unstructured":"Mark TL, Kranzler HR, Song X, Bransberger P, Poole VH, Crosse S. Physicians\u2019 opinions about medications to treat alcoholism. Addiction. 2003;98:617\u201326.","journal-title":"Addiction"},{"issue":"3","key":"134_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","volume":"50","author":"GM Curran","year":"2012","unstructured":"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217\u201326.","journal-title":"Med Care"},{"issue":"1","key":"134_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12913-016-1958-5","volume":"17","author":"AC Eldh","year":"2017","unstructured":"Eldh AC, Almost J, DeCorby-Watson K, et al. Clinical interventions, implementation interventions, and the potential greyness in between -a discussion paper. BMC Health Serv Res. 2017;17(1):16.","journal-title":"BMC Health Serv Res"},{"key":"134_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","volume":"10","author":"BJ Powell","year":"2015","unstructured":"Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10:21.","journal-title":"Implement Sci"},{"key":"134_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11606-013-2625-8","volume":"29","author":"DW Oslin","year":"2014","unstructured":"Oslin DW, Lynch KG, Maisto SA, et al. A randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs primary care clinics versus specialty addiction treatment. J Gen Intern Med. 2014;29:162\u20138.","journal-title":"J Gen Intern Med"},{"issue":"11","key":"134_CR32","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/jama.2013.277609","volume":"310","author":"R Saitz","year":"2013","unstructured":"Saitz R, Cheng DM, Winter M, et al. Chronic care management for dependence on alcohol and other drugs: the AHEAD randomized trial. JAMA. 2013;310(11):1156\u201367.","journal-title":"JAMA"},{"issue":"5","key":"134_CR33","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamainternmed.2018.0388","volume":"178","author":"KA Bradley","year":"2018","unstructured":"Bradley KA, Bobb JF, Ludman EJ, et al. Alcohol-related nurse care management in primary care: a randomized clinical trial. JAMA Intern Med. 2018;178(5):613\u201321.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"134_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13722-017-0080-2","volume":"12","author":"KA Bradley","year":"2017","unstructured":"Bradley KA, Ludman EJ, Chavez LJ, et al. Patient-centered primary care for adults at high risk for AUDs: the choosing healthier drinking options in primary care (CHOICE) trial. Addict Sci Clin Pract. 2017;12(1):15.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"134_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1353\/cpr.2017.0047","volume":"11","author":"KE Watkins","year":"2017","unstructured":"Watkins KE, Ober AJ, Lamp K, et al. Implementing the Chronic Care Model for opioid and alcohol use disorders in primary care. Prog Commun Health Partnersh Res Educ Action. 2017;11(4):397\u2013407.","journal-title":"Prog Commun Health Partnersh Res Educ Action"},{"issue":"10","key":"134_CR36","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jamainternmed.2017.3947","volume":"177","author":"KE Watkins","year":"2017","unstructured":"Watkins KE, Ober AJ, Lamp K, et al. Collaborative care for opioid and alcohol use disorders in primary care: the SUMMIT randomized clinical trial. JAMA Intern Med. 2017;177(10):1480\u20138.","journal-title":"JAMA Intern Med"},{"issue":"3","key":"134_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/jamainternmed.2017.8359","volume":"178","author":"KE Watkins","year":"2018","unstructured":"Watkins KE, Setodji C, McCullough CM. Necessary clarifications concerning results of the summit trial\u2014reply. JAMA Intern Med. 2018;178(3):429.","journal-title":"JAMA Intern Med"},{"key":"134_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13012-015-0256-7","volume":"10","author":"AJ Ober","year":"2015","unstructured":"Ober AJ, Watkins KE, Hunter SB, Lamp K, Lind M, Setodji CM. An organizational readiness intervention and randomized controlled trial to test strategies for implementing substance use disorder treatment into primary care: SUMMIT study protocol. Implement Sci. 2015;10:66.","journal-title":"Implement Sci"},{"issue":"1","key":"134_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13012-016-0431-5","volume":"11","author":"HJ Hagedorn","year":"2016","unstructured":"Hagedorn HJ, Brown R, Dawes M, et al. Enhancing access to Alcohol Use Disorder Pharmacotherapy and Treatment in Primary Care Settings: ADaPT\u2013PC. Implement Sci. 2016;11(1):64.","journal-title":"Implement Sci"},{"issue":"1","key":"134_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13722-016-0063-8","volume":"11","author":"AH Harris","year":"2016","unstructured":"Harris AH, Bowe T, Hagedorn H, et al. Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness. Addict Sci Clin Pract. 2016;11(1):15.","journal-title":"Addict Sci Clin Pract"},{"issue":"4","key":"134_CR41","doi-asserted-by":"publisher","first-page":"598","DOI":"10.15288\/jsad.2013.74.598","volume":"74","author":"SM Ornstein","year":"2013","unstructured":"Ornstein SM, Miller PM, Wessell AM, Jenkins RG, Nemeth LS, Nietert PJ. Integration and sustainability of alcohol screening, brief intervention, and pharmacotherapy in primary care settings. J Stud Alcohol Drugs. 2013;74(4):598\u2013604.","journal-title":"J Stud Alcohol Drugs"},{"key":"134_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jsat.2017.09.002","volume":"82","author":"AHS Harris","year":"2017","unstructured":"Harris AHS, Brown R, Dawes M, et al. Effects of a multifaceted implementation intervention to increase utilization of pharmacological treatments for alcohol use disorders in the US Veterans Health Administration. J Subst Abuse Treat. 2017;82:107\u201312.","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"134_CR43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.15288\/jsad.2017.78.735","volume":"78","author":"JH Ford 2nd","year":"2017","unstructured":"Ford JH 2nd, Abraham AJ, Lupulescu-Mann N, et al. Promoting adoption of medication for opioid and alcohol use disorders through system change. J Stud Alcohol Drugs. 2017;78(5):735\u201344.","journal-title":"J Stud Alcohol Drugs"},{"issue":"5","key":"134_CR44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jsat.2013.06.009","volume":"45","author":"S Robinson","year":"2013","unstructured":"Robinson S, Bowe T, Harris AH. Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption. J Subst Abuse Treat. 2013;45(5):475\u20137.","journal-title":"J Subst Abuse Treat"},{"issue":"12","key":"134_CR45","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/ACM.0000000000000846","volume":"90","author":"JP Seale","year":"2015","unstructured":"Seale JP, Johnson JA, Clark DC, et al. A multisite initiative to increase the use of alcohol screening and brief intervention through resident training and clinic systems changes. Acad Med. 2015;90(12):1707\u201312.","journal-title":"Acad Med"},{"issue":"1","key":"134_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/08897077.2015.1052868","volume":"37","author":"SJ Cousins","year":"2016","unstructured":"Cousins SJ, Denering L, Crevecoeur-MacPhail D, et al. A demonstration project implementing extended-release naltrexone in Los Angeles County. Subst Abus. 2016;37(1):54\u201362.","journal-title":"Subst Abus"}],"container-title":["Addiction Science & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-019-0134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13722-019-0134-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-019-0134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:12:27Z","timestamp":1581466347000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-019-0134-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1186\/s13722-019-0134-8","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"assertion":[{"value":"11 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}